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Introduction: Clean intermittent catheterization (CIC) is recommended for
bladder management after spinal cord injury (SCI) since it has the lowest
complication rate. However, transitions from CIC to other less optimal
strategies, such as indwelling catheters (IDCs) are common. In individuals
with SCI who stopped CIC, we sought to determine how individual
characteristics affect the bladder‐related quality of life (QoL) and the reasons
for CIC cessation.
Methods: The Neurogenic Bladder Research Group registry is an observational
study, evaluating neurogenic bladder‐related QoL after SCI. From 1479
participants, those using IDC or urinary conduit were asked if they had ever
performed CIC, for how long, and why they stopped CIC. Multivariable
regression, among participants discontinuing CIC, established associations
between demographics, injury characteristics, and SCI complications with
bladder‐related QoL.
Results: There were 176 participants who had discontinued CIC; 66 (38%) were
paraplegic and 110 (63%) were male. The most common reasons for CIC
cessation among all participants were inconvenience, urinary leakage, and too
many urine infections. Paraplegic participants who discontinued CIC had
higher mean age, better fine motor scores, and lower educational attainment
and employment. Multivariable regression revealed years since SCI was
associated with worse bladder symptoms (neurogenic bladder symptom score),
≥4 urinary tract infections (UTIs) in a year was associated with worse
satisfaction and feelings about bladder symptoms (SCI‐QoL difficulties), while
tetraplegia was associated better satisfaction and feelings about bladder
symptoms (SCI‐QoL difficulties).
Conclusions: Tetraplegics who have discontinued CIC have an improved QoL
compared with paraplegics. SCI individuals who have discontinued CIC and
have recurrent UTIs have worse QoL.
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1 | INTRODUCTION
After spinal cord injury (SCI), most individuals develop
neurogenic lower urinary tract dysfunction, which in the
majority of cases requires assisted bladder emptying
rather than volitional voiding. For most individuals with
SCI, this assisted bladder emptying includes catheter‐
based management, such as an indwelling catheter (IDC)
or clean intermittent catheterization (CIC). IDCs, either a
suprapubic tube (SPT) or Foley catheter, are associated
with more urologic and nonurologic complications,
including urinary tract infection (UTI), bladder and
kidney stones, renal insufficiency, hydronephrosis, in-
creased risk of bladder cancer, pressure ulcers, and all‐
cause hospitalizations.1-4 Therefore, most clinicians and
guidelines recommend CIC as the preferred bladder
management strategy in individuals with SCI who
require catheter‐based management.5-7 However, despite
the increased risk of complications associated with IDCs,
up to 70% of individuals with SCI who use CIC after their
injury transition to IDCs over time.8
The common reasons for management transitions
from CIC to IDC have not been thoroughly investigated.
Factors such as age, female sex, obesity, and upper
extremity motor impairment are known to affect the
ability to perform CIC.8-10 Clinical complications such as
persistent urinary leakage, urethral erosion/stricture,
perceived increased UTI risk, and autonomic dysreflexia
have also been cited as reasons for management
transitions.11 Recently, inconvenience with the frequency
and time required to catheterize and dislike of the
treatment modality has been associated with treatment
transitions.12,13 However, other than these small studies,
there is very little that is known about patient‐reported
factors associated with dissatisfaction with CIC and the
quality of life (QoL) among individuals that have
discontinued CIC. Crescenze et al14 showed that female
sex, earlier injury, recurrent UTIs, and severe bowel
dysfunction were associated with dissatisfaction and
worse QoL among SCI individuals currently performing
CIC. There are no similar studies regarding factors
associated with dissatisfaction among SCI individuals
who have discontinued CIC.
We examined the Neurogenic Bladder Research
Group (NBRG) prospective registry of SCI participants
to better understand factors associated with discontinua-
tion and dissatisfaction with CIC. We hypothesize that
individuals with SCI who have discontinued SCI with
recurrent UTIs, severe bowel dysfunction, and chronic
pain have worse QoL. In addition, tetraplegic individuals
who have discontinued CIC are likely to have an
improved QoL compared with paraplegics who have
discontinued CIC.
2 | METHODS
The NBRG registry is a prospective observational study
examining neurogenic‐bladder‐related QoL among indi-
viduals after SCI. The study was conducted at the
Universities of Michigan, Minnesota, and Utah, and
participants were recruited throughout the United States
and Canada. Participants were allowed to enroll in the
study through a telephonic interview and by answering
electronic questionnaires. The study protocol and meth-
ods have been previously published.15 Eligible partici-
pants included those with an acquired SCI who had
discontinued CIC, and were also ≥18 years of age and
spoke English. Individuals with progressive neurologic
disorders (ie, multiple sclerosis) and congenital spinal
cord malformations or neurologic injury (ie, cerebral
palsy, myelomeningocele, etc) were excluded.
Our analysis cohort consisted of subjects who had
discontinued CIC. Participants were asked about their
current and past bladder management strategies during
enrollment. Participants that reported IDC (SPT or Foley
catheter) or urinary conduit (ileal or colon conduit) as
their primary bladder management were asked if they
had ever performed CIC. If the participants indicated
they had done CIC in the past, they were asked about the
timing of CIC cessation, categorized as duration of CIC
for less than 1, 1 to 12, and greater than 12 months. We
gathered information about the participants from their
enrollment interview, including (a) demographics and
comorbidities: age, sex, education (bachelor’s degree or
higher), employment (employed for wages including
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self‐employed), and Charlson Comorbidity Index16, (b)
injury specifics: time from injury, injury level (either
tetraplegic [cervical level 1‐8] or paraplegic [thoracic,
sacral, cauda equina]), and fine motor function, and (c)
SCI complications: number of UTIs in the last year (self‐
reported rate as 0, 1‐3, ≥4), hospitalization for UTI in the
last year, chronic pain (do you experience chronic pain?),
as well as severe bowel dysfunction (neurogenic bowel
dysfunction score >14). The neurogenic bowel dysfunc-
tion score is a validated self‐reported measure of bowel
dysfunction.17
Self‐reported reasons for CIC discontinuation were
gathered during enrollment interview. Participants were
asked to select from a list of reasons for CIC discontinua-
tion and multiple responses could be selected (Table 3).
Participants were not asked to rank the reasons for CIC
discontinuation. We stratified this data by the duration of
CIC before cessation, sex, and level of injury.
2.1 | Outcome measures
Fine motor function was measured using the SCI‐QoL
measurement system fine motor functioning subdomain
that has been validated in individuals with SCI.18,19 This
item bank has a calibrated mean score of 50 with score
ranges between 0 and 100. A lower score conveys worse
fine motor function. Symptoms and QoL were assessed
using the neurogenic bladder symptom score (NBSS) and
the SCI‐QoL bladder management difficulties item
bank.18,20 The NBSS focuses on bladder‐related symp-
toms and complications with a score range between 0 and
74, with lower scores indicating fewer symptoms.20 The
NBSS also assesses satisfaction with the urinary system
with a single question: “if you had to live the rest of your
life with the way your bladder (or urinary reservoir)
currently works, how would you feel?” (range, 0–4).20
The SCI‐QoL difficulties item bank assesses feelings
about bladder function and urinary incontinence.18 This
item bank has a calibrated mean score of 50 with score
ranges between 0 and 100. A lower score indicates fewer
bladder difficulties.
2.2 | Statistical methods
Descriptive statistics of subjects who discontinued CIC
were stratified by injury level (paraplegic and tetraplegic)
including: means, standard deviations, medians, and
interquartile ranges for the continuous variables and
counts and column percentages for the categorical and
ordinal variables were calculated. Comparisons with
injury level for continuous variables were made using t
tests for the normally distributed variables and the
Wilcoxon signed‐rank test for the nonnormally
distributed variables and categorical variables using χ2
tests. Among the full cohort of SCI individuals who
discontinued CIC, univariable and multivariable linear
regression models were created using a prespecified list
of covariates that we hypothesized a priori. These models
were used to determine whether the QoL outcome
measures (NBSS total, NBSS satisfaction, and SCI‐QOL
bladder management difficulties) were significantly
associated with demographic, injury characteristics, or
injury‐related complications among SCI individuals who
discontinued SCI. Multivariable regression models were
adjusted for duration of CIC, level of injury, age, sex,
years since SCI, education, employment, severe bowel
dysfunction, chronic pain, number of patient‐perceived
UTIs, and hospitalization for UTIs. Coefficients, 99.6%
confidence intervals (CIs), and P values were reported
from the models. We adjusted the P values and 95% CIs
within each model for multiple comparisons using the
Bonferroni correction. Statistical analyses were con-
ducted using the SAS software, version 9.4, SAS Institute
Inc, Cary, NC.
3 | RESULTS
There were 1479 participants who enrolled in this study.
Of these participants, 309 (20.8%) identified their primary
management as an IDC or a urinary conduit. In these
participants, 176 (56.9%) had used CIC in the past and
discontinued this management for SPT (113, 64%), Foley
catheter (52, 29.5%), or urinary conduit (12, 6.8%).
Baseline characteristics of these participants are shown
in Table 1 stratified by level of injury. In the unadjusted
comparison between paraplegic and tetraplegic indivi-
duals who had discontinued CIC, paraplegic participants
who had discontinued CIC had an older mean age and a
larger proportion had a Charlson Comorbidity Index
greater than 1 compared with tetraplegic participants. A
significantly lower proportion of paraplegic participants
reported a bachelor’s degree or higher or employment
compared with tetraplegic participants. Paraplegic parti-
cipants had higher (better) fine motor scores compared
with tetraplegic participants. Paraplegic participants also
performed CIC a longer duration before cessation.
A higher proportion of paraplegic participants who
discontinued CIC reported chronic pain. Overall, 16% of
the cohort reported hospitalization for a UTI in the last
year. There was no difference in the number of patient‐
perceived UTI’s and hospitalization for UTI when
stratified by injury level.
The mean NBSS total score, NBSS satisfaction score,
and SCI‐QoL difficulties scores were improved in
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tetraplegic participants who discontinued CIC compared
with paraplegic participants (Table 1).
The reasons for CIC cessation among the 176
participants in our cohort are shown in Table 2. Among
the entire cohort, convenience (36%), urinary leakage
(20%), and the number of urinary infections (19%) were
the most common reasons for CIC cessation. The most
common reasons were similar when stratified by sex.
When responses were stratified by injury level, tetra-
plegic participants reported “I did not want to be
TABLE 1 Characteristics of spinal cord injury participants who discontinued clean intermittent catheterization
Variable Total (n = 176) Paraplegia (n = 66, 38%) Tetraplegia (n=110, 62%) P value*
Demographics
Sex, male, n (%) 110 (63%) 39 (59%) 71 (65%) .47
Age in y, mean (SD) 45.3 (12.8) 48.2 (13.8) 43.6 (11.9) .02
Education, bachelor’s degree or higher, n (%) 57 (32%) 10 (15%) 47 (43%) <.001
Employment, n (%) ω 41 (23%) 9 (14%) 32 (29%) .02
Charlson Comorbidity Index >1, n (%) 81 (46%) 38 (58%) 43 (39%) .02
Duration of CIC before cessation, n (%), mo
<1 20 (11.4%) 6 (9.1%) 14 (12.7%) .01
1‐12 54 (30.7%) 12 (18.2%) 42 (38.2%)
>12 102 (58.0%) 48 (72.7%) 54 (49.1%)
Injury characteristics
Years since SCI, median (IQR) 15.2 (7.1, 23.7) 16.9 (7.2, 28.4) 14.9 (6.5, 23.0) .40
Fine motor T score, mean (SD) 47.3 (9.0) 55.8 (4.9) 42.2 (6.7) <.001
Current bladder management
Indwelling catheter, n (%)
SPT 113 (64.2%) 38 (57.6%) 75 (68.2%) .36
Foley 52 (29.5%) 23 (34.8%) 29 (26.4%)
Urinary conduit 12 (6.8%) 5 (7.6%) 7 (6.4%) .76
Injury‐related complications
Number of UTIs, n (%)
0 37 (21%) 17 (26%) 20 (18%) .30
1‐3 79 (45%) 25 (38%) 54 (50%)
≥4 60 (34%) 24 (36%) 36 (32%)
Hospitalization for UTI, yes 29 (16%) 9 (14%) 20 (18%) .40
Severe bowel dysfunction, n (%) γ 88 (58%) 26 (51%) 62 (62%) .19
Chronic pain, yes, n (%) δ 118 (67%) 51 (77%) 67 (61%) .03
Bladder‐related QoL outcomes
NBSS‐mean (SD) 18.7 (10.1) 21.8 (11.7) 16.8 (8.6) .001
Median (IQR) 17.0 (11, 25) 20.5 (15, 28) 15.0 (10, 23)
NBSS satisfaction ϕ‐mean (SD) 2.0 (1.3) 2.3 (1.3) 1.8 (1.3) .01
Median (IQR) 2.0 (1.0, 3.0) 2.0 (1.0, 4.0) 2.0 (1.0, 2.0)
SCI‐QoL difficulties T score‐mean (SD) 57.0 (8.1) 59.8 (8.7) 55.3 (7.2) <.001
Median (IQR) 57.5 (52.6, 61.6) 59.5 (57.5, 64.8) 57.0 (50.9, 59.9)
Note: ω employment—making wages (including self‐employment), δ chronic pain—participants asked “do you experience chronic pain?” and γ severe bowel
dysfunction—neurogenic bowel dysfunction score ≥14. ϕ NBSS satisfaction is the final question of the NBSS “If you had to live your life with the way your
bladder (or urinary reservoir) currently works, how would you feel?”
Missing values: SCI‐FI fine motor T score = 2, severe bowel dysfunction = 25, hospitalization for UTI = 1, and SCI‐QOL bladder management difficulties T
score = 2.
Abbreviations: CIC, clean intermittent catheterization; IDC, indwelling catheter; IQR, interquartile range; NBSS, neurogenic bladder symptom score; QoL,
quality of life; SCI, spinal cord injury; SCI‐QoL, spinal cord injury measurement system; SCI‐QoL difficulties, bladder management difficulties item bank; SPT,
suprapubic tube; UTI, urinary tract infection.
*Analysis of variance or χ2 test as appropriate.
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dependent on others” as the second most common reason
for CIC cessation compared with none of the paraplegic
respondents. In participants who had discontinued CIC
within 1 month of initiation, poor hand function, and
body positioning were more common reasons compared
with longer duration of CIC before discontinuation.
Multivariate linear regression models examining the
associations between demographics and comorbidities,
injury characteristics, and SCI complications on the
mean NBSS total score, NBSS satisfaction score, and SCI‐
QoL difficulties scores are shown in Table 3. Among SCI
participants who had discontinued CIC, years from SCI
were associated with worse NBSS total scores. In
addition, participants who discontinued CIC who re-
ported ≥4 patient‐perceived UTI within the last year, had
significantly worse NBSS total scores and SCI‐QoL
difficulties scores. Tetraplegic participants had improved
NBSS satisfaction and SCI‐QoL difficulties scores.
TABLE 3 Multivariate regressiona of effects of demographics, injury characteristics, and injury‐related complications on NBSS total




















Sex, male −1.6 (−6.1, 3.0) 1.00 −0.1 −0.7, 0.5) 1.00 −1.1 (−4.8, 2.5) 1.00




−1.8 (−6.9, 3.2) 1.00 −0.2 (−0.8, 0.5) 1.00 −1.3 (−5.3, 2.7) 1.00
Employment ω −2.1 (−7.6, 3.4) 1.00 0.2 (‐0.5, 0.9) 1.00 −0.9 (−5.3, 3.5) 1.00
Duration of CIC
before cessation, mo
<1 (reference) ⋯ ⋯ ⋯ ⋯ ⋯ ⋯
1‐12 4.2 (−3.7, 12.0) 1.00 0.3 (−0.7, 1.3) 1.00 0.6 (−5.6, 6.9) 1.00
>12 4.7 (−2.5, 12.0) .73 0.3 (−0.7, 1.2) 1.00 1.9 (−3.9, 7.7) 1.00
Injury characteristics




⋯ ⋯ ⋯ ⋯ ⋯ ⋯




0 (reference) ⋯ ⋯ ⋯ ⋯ ⋯ ⋯
1‐3 4.3 (−1.6, 10.1) .45 0.5 (−0.2, 1.3) .55 4.0 (−0.7, 8.7) .19
≥4 7.6 (1.1, 14.1) .01 0.8 (−0.0, 1.6) .06 5.6 (0.4, 10.8) .02
Hospitalization for
UTI, yes
−1.6 (−8.7, 5.4) 1.00 0.6 (−0.3, 1.5) .59 ‐1.7 (−7.4, 4.0) 1.00
Severe bowel
dysfunction γ
1.9 (−2.9, 6.6) 1.00 0.0 (−0.6, 0.6) 1.00 1.5 (−2.3, 5.3) 1.00
Chronic pain, yes δ 0.4 (−4.4, 5.2) 1.00 0.1 (−0.5, 0.8) 1.00 −0.9 (−4.7, 2.9) 1.00
Note: ω employment—making wages (including self‐employment), γ severe bowel dysfunction—neurogenic bowel dysfunction score ≥14, and δ chronic pain—
participants were asked “do you experience chronic pain?” ϕ NBSS satisfaction is the final question of the NBSS “If you had to live your life with the way your
bladder (or urinary reservoir) currently works, how would you feel?”
Abbreviations: CIC, clean intermittent catheterization; NBSS, neurogenic bladder symptom score; QoL, quality of life; SCI, spinal cord injury; SCI‐QoL, spinal
cord injury measurement system; SCI‐QoL difficulties, bladder management difficulties item bank; UTI, urinary tract infection.
aAdjusting for the duration of CIC, level of injury, age, sex, years since SCI, education, employment, severe bowel dysfunction, chronic pain, number of UTIs,
and hospitalization for UTIs.
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4 | DISCUSSION
Catheter‐based management is common after SCI.
However, despite the established higher clinical compli-
cations associated with certain strategies such as IDC,
there is a little that is known about the characteristics of
individuals with SCI who transition to IDC or urinary
conduit from CIC or the reasons they make this decision.
We examined the NBRG prospective registry to better
understand reasons for CIC discontinuation and factors
associated with dissatisfaction among those SCI partici-
pants who have discontinued CIC. The top three self‐
reported reasons for CIC cessation for the entire cohort
were inconvenience, urinary leakage, and too many urine
infections. We found that despite lower fine motor scores
among tetraplegic participants that discontinued CIC,
these participants had improved bladder‐related QoL
when compared with paraplegic participants who dis-
continued CIC. Participants who discontinued CIC and
had recurrent UTIs (≥4 patient‐perceived UTI within the
last year) had worse bladder‐related QoL. Severe bowel
dysfunction and chronic pain were not associated with
changes in bladder‐related QoL among SCI participants
who discontinued CIC.
Prior studies evaluating the reasons for treatment
transition among individuals with SCI have been limited
in their number and scope. Afsar et al11 explored reasons
for discontinuation of CIC in a retrospective review of
recently injured individuals with SCI at a single institu-
tion. At discharge from rehabilitation, 104 (64%) indivi-
duals were performing CIC, while subsequent follow‐up
showed that only 60 (37.5%) of individuals continued CIC
and 9 (21%) had transitioned from CIC to IDC for bladder
management. The authors reported recurrent UTI,
urinary incontinence, urolithiasis, the dependence of
caregivers, and urethral strictures as reasons for dis-
continuation of CIC. Age, sex, education, and level of
injury were not associated with compliance with CIC. In
another study, 248 members of the Norwegian Spinal
Cord Injuries Association were surveyed, and the leading
reasons given for bladder management other than CIC
included: “it suits me best” (24%) and “it gives me
flexibility with more options” (21%).21 When stratified by
injury level (paraplegic vs tetraplegic), the authors found
a significant difference in responses, with tetraplegic
individuals reporting “it gives me flexibility with more
options,” “it does nt constrain my daily activities,” “it is
less time consuming,” and “it suits me best” more often
than paraplegic participants. Responses were not mu-
tually exclusive and were not stratified by injury level.
More recently, Lane et al12 presented their survey
results of 100 veterans with prior traumatic SCI at the
Minneapolis Veterans Affairs Medical Center. They
found that 22 of the 46 participants (48%) using IDC
had prior history of CIC which had been discontinued.
The authors found that the most common reasons for the
transition from CIC were inconvenience (n = 5), clinician
recommendation (n = 5), and dislike of CIC (n = 4).
Clinician recommendation was an unexpected reason for
treatment transition given the well‐established goals in
SCI care of maintaining CIC when possible and may
suggest knowledge gaps about the higher complications
associated with IDCs.
Zlatev et al10 previously demonstrated that impair-
ment in upper extremity motor function is an important
predictor of long‐term CIC adoption. For patients that
performed CIC for shorter durations before discontinua-
tion, patient‐reported reasons of “I could not catheterize
because of poor hand function” and “I could not
catheterize because positioning my body was too
difficult” are reflective. However, overall, the most
common reasons for CIC discontinuation included
inconvenience, urinary incontinence, and recurrent
UTI. This suggests poor participant understanding of
clinical complications associated with various bladder
management strategies, as it is well known that IDC have
the highest relative rate of urinary complications includ-
ing recurrent UTI.1,22 These self‐reported reasons from a
large cohort of SCI participants who discontinued CIC
may be helpful in designing interventions to improve
long‐term CIC adoption.
Interestingly, we also found that tetraplegic partici-
pants who discontinued CIC had lower (improved) NBSS
satisfaction and SCI‐QoL difficulties scores compared
with paraplegic participants, although this association
was relatively small. Myers et al23 show similar findings
in another analysis performed using this registry. The
authors found that both tetraplegic and paraplegic
participants using IDC as primary bladder management
strategy had lower (improved) NBSS total scores. How-
ever, tetraplegic participants reporting IDC as primary
bladder management strategy had significantly lower
(improved) SCI‐QoL difficulties scores. This association
was not significant among paraplegic participants using
IDC. Overall QoL among tetraplegic participants using
CIC as the primary bladder management strategy is likely
related to improvement in urinary concerns.24 In a study
of SCI participants performing CIC alone, CIC with
botulinum toxin, and CIC with augmentation cystoplasty,
tetraplegia had lower (improved) NBSS total and SCI‐
QoL difficulties.25 Conversely, there was no association
between the level of injury and fine motor hand function
on dissatisfaction among participants reporting CIC as a
bladder management strategy, when patients who under-
went any procedure to improve urinary‐related QoL were
excluded.14
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There are several notable limitations to this study.
One limitation is that this study uses participant‐reported
data based on their perception of their health, which had
not been corroborated with clinical data or chart review,
such as information regarding urinary infections. Also,
we did not ask participants to rank the most important
reasons for discontinuation of CIC, which limits our
analysis. We chose to stratify our findings based on injury
level (paraplegia vs tetraplegia) in the multivariable
analysis as a proxy for upper extremity motor function
rather than use fine motor scores as we felt there would
be too much collinearity. Inclusion bias is also a common
limitation of survey studies; those participants with
bladder problems are more likely to enter the study in
hopes of learning more about their bladder. Finally, there
is potential for recall errors for specific reported variables,
such as duration of CIC before discontinuation, which
may impact our findings.
However, this study is strengthened by a large diverse
study population and extensive yet robust data about
demographics, injury characteristics, SCI complications,
and patient‐reported outcomes. Understanding how
these characteristics influence QoL in individuals who
transition their bladder management from CIC, as well as
the reasons that individuals decide to transition their
management, is paramount to developing shared deci-
sion‐making tools to individualize the optimal bladder
management strategy for SCI. Decision aids may avoid
management transitions to less optimal bladder strategies
by educating, addressing individuals concerns, and
potential QoL issues with transitioning management.
Discrepancies exist between clinical and patient‐reported
outcomes for bladder management among individuals
with SCI; however, a careful balance between avoiding
complications and the best bladder‐related QoL is
essential.
5 | CONCLUSION
In this analysis of the NBRG prospective registry, we found
that the most common self‐reported reasons for CIC
cessation among individuals with SCI were inconvenience,
urinary leakage, and too many urine infections. Participants
with tetraplegia who had discontinued CIC had greater
satisfaction with their urinary system and less impact of
bladder symptoms in their QoL compared with participants
with paraplegia. Participants who discontinued CIC and had
recurrent UTIs (≥4 patient‐perceived UTI within the last
year) had worse bladder‐related QoL. An individualized
approach aimed at balancing clinical complications with
QoL concerns is needed when exploring treatment transi-
tions for SCI bladder management.
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